Study: Race influences warfarin dose
6/01/2015
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race.
Targeted drug can 'diminish the suffering' of myelofibrosis say Mayo Clinic researchers
6/01/2015
Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic researcher who co-led PERSIST-1, the worldwide phase III...
Western diet could be fatal for prostate cancer patients
6/01/2015
Researchers suggest that a diet high in red and processed meats, refined grains and high-fat dairy products could lead to an increased risk of death for prostate cancer patients.
Global cancer cases 'still rising' - now 15 million a year
6/01/2015
The social impact in more developed countries of living with cancer is 'staggering,' and the focus on prevention, particularly for developing countries, needs to move to treatment.
Late cancer relapse driven by 'reawakening of sleeping cancer cells'
5/31/2015
Cancer cells can avoid chemotherapy by going to sleep, laying dormant for years before they reawaken decades later, according to a new study by UK researchers.
Oral cancer therapy combination prevents progression of advanced melanoma for over a year
5/30/2015
Cobimetinib and Zelboraf®* (vemurafenib) target MEK and BRAF cell signals respectively to prevent disease progression in most aggressive form of skin cancerData from the pivotal coBRIM Phase...
Increasing body mass index linked with worse localized prostate cancer outcomes
5/29/2015
An increasing body mass index (BMI) was associated with a higher rate of prostate cancer relapse, prostate cancer death, and death from any cause among men treated with dose-escalated...
Controlling typhoid bacterium key to prevent gallbladder cancer in India and Pakistan
5/29/2015
Controlling bacterial infections responsible for typhoid fever could dramatically reduce the risk of gallbladder cancer in India and Pakistan, according to a study published by Cell Press May 28th...
Sanford-Burnham researchers identify a new target for treating drug-resistant melanoma
5/29/2015
A new collaborative study led by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), published in Cell Reports, provides new insight into the molecular changes that lead to...
Data to be presented at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) suggest that the investigational immunotherapy MPDL3280A may double the likelihood of overall...